个人简介
阿莱桑德拉·齐利医生是由西尔维奥·达内塞教授领导的圣拉斐尔医院胃肠病和消化内镜科的胃肠病专家。
她于2011年毕业于米兰大学医学与外科学专业,并于2017年在同一所大学完成了胃肠病学与消化内镜专科培训。2016年,她获得了意大利超声医学会(SIUMB)颁发的临床超声诊断证书。
齐利医生在炎症性肠病中心(IBD Center)从事慢性炎症性肠病(溃疡性结肠炎、克罗恩病)的临床工作,擅长消化内镜检查、上腹部和肠襻的超声检查,并作为多项实验性治疗研究项目的副研究员参与科研工作。
她是65篇学术出版物的作者或合著者,积极参与国内外专业会议,是欧洲克罗恩病与结肠炎组织(ECCO)和国际肠道超声学会(IBUS)的成员,并在IBUS负责为从事肠道超声的胃肠病专家提供培训。
出版物
最新出版物
Endoscopy and histology in inflammatory bowel diseases patients: Complementary or alternatives?
United European Gastroenterol J. 2022 Mar;10(2):141-142.
Artificial Endoscopy and Inflammatory Bowel Disease: Welcome to the Future
J Clin Med. 2022 Jan 24;11(3):569.
JAK inhibitors in crohn's disease: ready to go?
Expert Opin Investig Drugs. 2022 Feb;31(2):145-161.
Evolution and New Horizons of Endoscopy in Inflammatory Bowel Diseases
J Clin Med. 2022 Feb 7;11(3):872.
Cross-Sectional Imaging Instead of Colonoscopy in Inflammatory Bowel Diseases: Lights and Shadows
J Clin Med. 2022 Jan 12;11(2):353.
Colorectal Cancer Surveillance in Patients with Inflammatory Bowel Diseases: Chromoendoscopy or Non-Chromoendoscopy, That Is the Question
J Clin Med. 2022 Jan 20;11(3):509.
Carcinomas in inflammatory bowel disease: a narrative review on diagnostic imaging techniques
Chin Clin Oncol. 2022 Jun;11(3):22.
Gastrointestinal system, COVID-19 and potential mechanisms associated with coagulopathy
Curr Drug Targets. 2022 Sep 22.
Use of IBD Drugs in Patients With Hepatobiliary Comorbidities: Tips and Tricks
Inflamm Bowel Dis. 2022 Aug 30:izac189.
Predictive Value of Bowel Ultrasound in Crohn's Disease: A 12-Month Prospective Study
Clin Gastroenterol Hepatol. 2022 Apr;20(4):e723-e740.
Predictive value of Milan ultrasound criteria in ulcerative colitis: A prospective observational cohort study
United European Gastroenterol J. 2022 Mar;10(2):190-197.
Ulcerative colitis: Impact of early disease clearance on long-term outcomes
Bowel ultrasound score is accurate in assessing response to therapy in patients with Crohn's disease
Aliment Pharmacol Ther. 2022 Feb;55(4):446-454.
Early Biological Therapy in Operated Crohn's Disease Patients Is Associated With a Lower Rate of Endoscopic Recurrence and Improved Long-term Outcomes: A Single-center Experience
Inflamm Bowel Dis. 2022 May 28:izac110.
A New Potential Target in the Treatment of Inflammatory Bowel Disease
Curr Drug Targets. 2021;22(7):760-769.